Ergoteles LLC Spectrum Pharmaceuticals Inc Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.31 $1.51 Million - $3.05 Million	2,329,817 New	2,329,817 $2.24 Million
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.52 $105,825 - $171,967	-330,706 Reduced 86.59%	51,196 $18,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $155,820 - $565,301	-362,373 Reduced 48.69%	381,902 $164,000
Q2 2022 Aug 12, 2022	BUY	$0.7 - $1.4 $311,689 - $623,378	445,270 Added 148.92%	744,275 $581,000
Q1 2022 May 13, 2022	BUY	$0.63 - $1.59 $188,373 - $475,417	299,005 New	299,005 $386,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $80,391 - $153,186	-63,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $136,095 - $241,806	63,300 New	63,300 $138,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.